CME vs SER · P/E 22, rev $6.52B vs rev $56.0K
CME Group Inc (CME) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
CME currently screens at market cap $91.25B and trailing P/E 21.9. SER currently screens at market cap $29.7M.
Not investment advice. Open the CME and SER stock pages for the full models.
Not investment advice.